{
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3025, 
        3039
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3945, 
        3968
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2762, 
        2789
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        445, 
        474
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2268, 
        2303
      ]
    }
  ], 
  "Negative Findings Phraseology (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3483, 
        3506
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2835, 
        2841
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3006, 
        3014
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3179, 
        3185
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3252, 
        3258
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3652, 
        3658
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3723, 
        3729
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3915, 
        3921
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2842, 
        2858
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3015, 
        3024
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3186, 
        3202
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3259, 
        3275
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3659, 
        3675
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3730, 
        3746
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3922, 
        3938
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2811, 
        2821
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2884, 
        2894
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2983, 
        2992
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3157, 
        3166
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3228, 
        3238
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3301, 
        3311
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3400, 
        3409
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3532, 
        3541
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3630, 
        3638
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3702, 
        3710
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3773, 
        3782
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3893, 
        3902
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2791, 
        2792
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 11^9311^MOH|PIMS|CCO|20160602124212|A85A9D8A1D8B480AFF287A54FEE0F15AC36DC6DE|ORU^R01|99999999999999999999|P|2.5|||||\nPID|1||^^^^MRN^HOSPITAL 11&9999&MOH~9999999999&TL&ON^^^^JHN||XXXXXX^XXXXXXX^||99999999|M||||||||||||||||||||||N|\nOBR|1||BZ00605802|11529-5^Surgical Pathology Study Report^LN^BX^Biopsy^L|||20160525|||65206^XXXXXXX-XXXXXXX^XXXXX^^^XX.||||||||||||20160602|||C|||||||99999^XXXXX^XXXXX^XXXX^^XX|\n\n\n\n\n\n\n\nPath report.gross description\n\n1.Specimen consists of 1 tan tissue corenE\\measuring 16 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\2.Specimen consists of 1 tan tissue corenE\\measuring 15 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\3.Specimen consists of 1 tan tissue corenE\\measuring 21 mm and 1 fragment measuring in totalnE\\1 mm in length by less than 1 mm in diameter.nE\\Embedded in toto.nE\nE\\4.Specimen consists of 1 tan tissue corenE\\measuring 14 mm and 1 fragment measuring in totalnE\\2 mm in length by less than 1 mm in diameter.nE\\Embedded in toto.nE\nE\\5.Specimen consists of 1 tan tissue corenE\\measuring 16 mm and 1 fragment measuring in totalnE\\2 mm in length by less than 1 mm in diameter.nE\\Embedded in toto.nE\nE\\6.Specimen consists of 1 tan tissue corenE\\measuring 18 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\7.Specimen consists of 1 tan tissue corenE\\measuring 15 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\8.Specimen consists of 1 tan tissue corenE\\measuring 15 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\9.Specimen consists of 1 tan tissue corenE\\measuring 16 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\10.Specimen consists of 1 tan tissue corenE\\measuring 18 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\11.Specimen consists of 1 tan tissue corenE\\measuring 16 mm and 1 fragment measuring in totalnE\\1 mm in length by less than 1 mm in diameter.nE\\Embedded in toto.nE\nE\\12.Specimen consists of 1 tan tissue corenE\\measuring 18 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\\\n\n\nPath report.microscopic observation\n\nTumour TypenE\\Adenocarcinoma, conventional typenE\nE\\ExtentnE\\# sites involved/total sites  1 / 12nE\\# cores involved/total cores  1 / 12nE\\Overall % tissue involved  1%nE\\% involvement in mostnE\\extensively involved core  15%nE\nE\\GleasonnE\\Overall Gleason Score (1?, worst)7 (3, 4)nE\\Highest Gleason Score (any site)7 (3, 4)nE\\% Gleason patterns 4, 5  40%nE\nE\\OthernE\\Perineural invasion     Not identifiednE\\Periprostatic fat invasion  Not identifiednE\\\n\n\nPath report.final diagnosis\n\n1.BIOPSY, PROSTATE (RIGHT BASE LATERAL)nE\\- BENIGN PROSTATIC TISSUE.nE\nE\\2.BIOPSY, PROSTATE (RIGHT BASE MEDIAL)nE\\- FOCAL GLANDULAR ATROPHY, NEGATIVE FORnE\\MALIGNANCY.nE\nE\\3.BIOPSY, PROSTATE (RIGHT MID LATERAL)nE\\- INVASIVE PROSTATIC ADENOCARCINOMA; GLEASONnE\\SCORE 7/10 (PRIMARY 3, SECONDARY 4); 1/1 COREnE\\INVOLVED; 15% TISSUE INVOLVEMENT.nE\nE\\4.BIOPSY, PROSTATE (RIGHT MID MEDIAL)nE\\- BENIGN PROSTATIC TISSUE.nE\nE\\5.BIOPSY, PROSTATE (RIGHT APEX LATERAL)nE\\- BENIGN PROSTATIC TISSUE.nE\nE\\6.BIOPSY, PROSTATE (RIGHT APEX MEDIAL)nE\\- FOCAL GLANDULAR ATROPHY, NEGATIVE FORnE\\MALIGNANCY.nE\nE\\7.BIOPSY, PROSTATE (LEFT BASE LATERAL)nE\\- FOCAL ACTIVE CHRONIC INFLAMMATION WITHnE\\GLANDULAR ATROPHY, NEGATIVE FOR MALIGNANCY.nE\nE\\8.BIOPSY, PROSTATE (LEFT BASE MEDIAL)nE\\- FOCAL GLANDULAR ATROPHY, NEGATIVE FORnE\\MALIGNANCY.nE\nE\\9.BIOPSY, PROSTATE (LEFT MID LATERAL)nE\\- BENIGN PROSTATIC TISSUE.nE\nE\\10.BIOPSY, PROSTATE (LEFT MID MEDIAL)nE\\- BENIGN PROSTATIC TISSUE.nE\nE\\11.BIOPSY, PROSTATE (LEFT APEX LATERAL)nE\\- FOCAL ATYPICAL SMALL ACINAR PATTERN (ASAP) OFnE\\UNCERTAIN SIGNIFICANCE.nE\nE\\12.BIOPSY, PROSTATE (LEFT APEX MEDIAL)nE\\- BENIGN PROSTATIC TISSUE.nE\\\n\n\nPath report.relevant Hx\n\nPSA Total: 7.5 ng/mLnE\\Ratio:  21%nE\\DRE Findings:  BPHnE\\Volume (cc):  57nE\\TRUS Findings:  NormalnE\nE\\Not providednE\\\n\n\n"
}